Acrolein, a highly toxic aldehyde generated under oxidative stress in vivo, aggravates the mouse liver damage after acetaminophen overdose

Biomedical Research (Japan)

Volumn 35, Issue 6, 2014, Pages 389-395

  Arai, Tomoya ^a   Koyama, Ryo ^a   Yuasa, Makoto ^a   Kitamura, Daisuke ^a   Mizuta, Ryushin ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACROLEIN; MESNA; PARACETAMOL; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MECHANISM; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER INJURY; MOUSE; NONHUMAN; OXIDATIVE STRESS; ANIMAL; C57BL MOUSE; CULTURE TECHNIQUE; DRUG EFFECTS; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MUS;

ACETAMINOPHEN; ACETYLCYSTEINE; ACROLEIN; ANIMALS; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; DRUG OVERDOSE; DRUG-INDUCED LIVER INJURY; LIVER; MESNA; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84919653572     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.35.389     Document Type: Article

References (22)

1. Aruoma OI, Halliwell B, Hoey BM and Butler J (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 6, 593-597.
2. Calingasan NY, Uchida K and Gibson GE (1999) Proteinbound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72, 751-756.
3. Daimon M, Sugiyama K, Kameda W, Saitoh T, Oizumi T, Hirata A, Yamaguchi H, Ohnuma H, Igarashi M and Kato T (2003) Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr J 50, 61-67.
4. Hamann K, Durkes A, Ouyang H, Uchida K, Pond A and Shi R (2008) Critical role of acrolein in secondary injury following ex vivo spinal cord trauma. J Neurochem 107, 712-721.
5. Ishida Y, Kondo T, Kimura A, Tsuneyama K, Takayasu T and Mukaida N (2006) Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur J Immunol 36, 1028-1038.
6. Kaplowitz N (2004) Acetaminophen hepatoxicity: what do we know, what don't we know, and what do we do next? Hepatology 40, 23-26.
7. Kehrer JP and Biswal SS (2000) The molecular effects of acrolein. Toxicol Sci 57, 6-15.
8. Lovell MA, Xie C and Markesbery WR (2001) Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194.
9. Mizuta R, Araki S, Furukawa M, Furukawa Y, Ebara S, Shiokawa D, Hayashi K, Tanuma S and Kitamura D (2013) DNase γ is the effector endonuclease for internucleosomal DNA fragmentation in necrosis. PLoS One 8, e80223.
10. Mohammad MK, Avila D, Zhang J, Barve S, Arteel G, McClain C and Joshi-Barve S (2012) Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress. Toxicol Appl Pharmacol 265, 73-82.
11. Perry HE and Shannon MW (1998) Efficacy of oral versus intravenous N-acetylcysteine in acetaminophen overdose: results of an open-label, clinical trial. J Pediatr 132, 149-152.
12. Saiki R, Park H, Ishii I, Yoshida M, Nishimura K, Toida T, Tatsukawa H, Kojima S, Ikeguchi Y, Pegg AE, et al. (2011) Brain infarction correlates more closely with acrolein than with reactive oxygen species. Biochem Biophys Res Commun 404, 1044-1049.
13. Sakata K, Kashiwagi K, Sharmin S, Ueda S, Irie Y, Murotani N and Igarashi K (2003) Increase in putrescine, amine oxidase, and acrolein in plasma of renal failure patients. Biochem Biophys Res Commun 305, 143-149.
14. Sener G, Sehirli O, Cetinel S, Yeğen BG, Gedik N and Ayanoğlu-Dülger G (2005) Protective effects of MESNA (2-mercaptoethane sulphonate) against acetaminophen-induced hepatorenal oxidative damage in mice. J Appl Toxicol 25, 20-29.
15. Shamoto-Nagai M, Maruyama W, Hashizume Y, Yoshida M, Osawa T, Riederer P and Naoi M (2007) In parkinsonian substantia nigra, alpha-synuclein is modified by acrolein, a lipid-peroxidation product, and accumulates in the dopamine neurons with inhibition of proteasome activity. J Neural Transm 114, 1559-1567.
16. Sharmin S, Sakata K, Kashiwagi K, Ueda S, Iwasaki S, Shirahata A and Igarashi K (2001) Polyamine cytotoxicity in the presence of bovine serum amine oxidase. Biochem Biophys Res Commun 282, 228-235.
17. Takahashi T, Morita K, Akagi R and Sassa S (2004) Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries. Curr Med Chem 11, 1545-1561.
18. Takamoto S, Sakura N, Yashiki M and Kojima T (2003) Inactivation of acrolein by sodium 2-mercaptoethanesulfonate using headspace-solid-phase microextraction gas chromatography and mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 791, 365-369.
19. Uchida K, Kanematsu M, Morimitsu Y, Osawa T, Noguchi N and Niki E (1998) Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins. J Biol Chem 273, 16058-16066.
20. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, et al. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci USA 95, 4882-4887.
21. Weinhold B (2011) Acrolein and neuro disorders. Environ Health Perspect 119, A68.
22. Yoshida M, Tomitori H, Machi Y, Hagihara M, Higashi K, Goda H, Ohya T, Niitsu M, Kashiwagi K and Igarashi K (2009) Acrolein toxicity: Comparison with reactive oxygen species. Biochem Biophys Res Commun 378, 313-318.